CardioComm Solutions Inc. (EKG) — Capital Reinvestment Ratio
Latest as of September 2022:
0.20x
CardioComm Solutions Inc. (EKG) has a Capital Reinvestment Ratio of 0.20x as of September 2022, meaning it reinvests 0% of its operating cash flow (CA$39.73K) in capital expenditures (CA$7.99K). See EKG free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.20x
Capex / Operating Cash Flow
Operating Cash Flow
CA$39.73K
CAD
Capital Expenditures
CA$7.99K
CAD
Data as of
Sep 2022
Most recent filing
CardioComm Solutions Inc. Capital Reinvestment Ratio (2020–2022)
This chart tracks CardioComm Solutions Inc.'s Capital Reinvestment Ratio across 2 annual periods.
Annual Capital Reinvestment Ratio for CardioComm Solutions Inc. (2020–2022)
Year-by-year Capital Reinvestment Ratio for CardioComm Solutions Inc. from 2020 to 2022. For live market cap and broader valuation context, see CardioComm Solutions Inc. stock valuation.
| Year | Reinvestment Ratio | Operating CF (CAD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.04x | CA$54.52K | CA$2.20K | ▼ -88.1% |
| 2020 | 0.34x | CA$39.40K | CA$13.37K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow